her2climb: tucatinib in combination w/ capecitabine & trastuzumab
Published 4 years ago • 236 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
-
1:12
her2climb-04: tucatinib trastuzumab deruxtecan in her2 breast cancer
-
1:47
her2climb-05: tucatinib trastuzumab and pertuzumab as maintenance therapy for her2 metastatic bc
-
3:15
her2climb-02: tucatinib tdm-1 in advanced breast cancer
-
5:50
her2climb: investigating tucatinib with capecitabine and trastuzumab in her2-positive metastatic...
-
1:16
her2climb-04: tucatinib plus t-dxd for her2 breast cancer
-
1:46
choosing between tucatinib and t-dxd in her2 breast cancer
-
0:36
tucatinib & trastuzumab /- chemo or pembrolizumab in unresectable or metastatic her2 gi cancers
-
1:51
tucatinib combination improved survival in her2–positive breast cancer
-
4:30
tucatinib for the treatment of her2 breast cancer
-
2:08
recent progress in managing brain metastasis in breast cancer
-
5:14
her2 mbc: systemic therapies and her2climb-02 trial
-
1:14
updated analysis from mountaineer: tucatinib and trastuzumab for her2-positive mcrc
-
0:56
mountaineer results: trastuzumab and tucatinib for her2 mcrc
-
0:55
her2climb-05: tucatinib with trastuzumab and pertuzumab as maintenance therapy for her2 mbc
-
2:10
treating cns metastases in her2 breast cancer
-
1:30
tucatinib in her2 breast cancer with leptomeningeal metastases
-
7:38
tucatinib plus trastuzumab & capecitabine for patients with her2-positive breast cancer & brain mets